Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Number of holders
-
423
-
Total 13F shares, excl. options
-
171,446,875
-
Shares change
-
+2,398,155
-
Total reported value, excl. options
-
$15,566,292,229
-
Value change
-
+$225,362,433
-
Put/Call ratio
-
124%
-
Number of buys
-
200
-
Number of sells
-
180
-
Price
-
$90.82
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q2 2017
As of 30 Jun 2017 BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) had 496 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 171,446,875 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, VANGUARD GROUP INC, JENNISON ASSOCIATES LLC, BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, FMR LLC, SANDS CAPITAL MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, Invesco Ltd., and STATE STREET CORP.
This table shows 496 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.